Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bernhardt

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
American Journal of Botany|June 2, 2011
Transmitting tissue architecture in basal-relictual angiosperms: Implications for transmitting tissue originsTammy L Sage, Katerina Hristova-Sarkovski, Veronica Koehl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2022
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based <sup>177</sup>Lu-DOTATATE treatment of NET patientsAnna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, et al.
EJNMMI Physics|July 6, 2018
Feasibility of simplifying renal dosimetry in <sup>177</sup>Lu peptide receptor radionuclide therapyAnna Sundlöv, Johan Gustafsson, Gustav Brolin, et al.
Transplantation Reviews (Orlando, Fla.)|October 26, 2021
An overview of the efficacy and safety of everolimus in adult solid organ transplant recipientsHelio Tedesco-Silva, Faouzi Saliba, Markus J Barten, et al.
Ecology and Evolution|June 26, 2018
Does reproductive isolation reflect the segregation of color forms in <i>Spiranthes sinensis</i> (Pers.) Ames complex (Orchidaceae) in the Chinese Himalayas?Zhi-Bin Tao, Zong-Xin Ren, Peter Bernhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 StudyChristopher Eigler, Lisa McDougall, Andreas Bauman, et al.
Cardiology Journal|October 25, 2017
Myocardial strain characteristics and outcomes after transcatheter aortic valve replacementDominik Buckert, Raid Tibi, Maciej Cieslik, et al.
Transplantation|March 24, 2023
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM StudyClaudia Sommerer, Christophe Legendre, Franco Citterio, et al.
Cancers|April 30, 2021
Dosimetric Analysis of the Short-Ranged Particle Emitter <sup>161</sup>Tb for Radionuclide Therapy of Metastatic Prostate CancerPeter Bernhardt, Johanna Svensson, Jens Hemmingsson, et al.
EJNMMI Physics|May 9, 2026
Multiple vertebrae improves precision in image-based bone marrow absorbed dose estimation in [<sup>177</sup>Lu]Lu-DOTATATE treatmentKatja Smits, Frida Westerbergh, Jens Hemmingsson, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
American Journal of Botany|June 2, 2011
Transmitting tissue architecture in basal-relictual angiosperms: Implications for transmitting tissue originsTammy L Sage, Katerina Hristova-Sarkovski, Veronica Koehl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2022
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based <sup>177</sup>Lu-DOTATATE treatment of NET patientsAnna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, et al.
EJNMMI Physics|July 6, 2018
Feasibility of simplifying renal dosimetry in <sup>177</sup>Lu peptide receptor radionuclide therapyAnna Sundlöv, Johan Gustafsson, Gustav Brolin, et al.
Transplantation Reviews (Orlando, Fla.)|October 26, 2021
An overview of the efficacy and safety of everolimus in adult solid organ transplant recipientsHelio Tedesco-Silva, Faouzi Saliba, Markus J Barten, et al.
Ecology and Evolution|June 26, 2018
Does reproductive isolation reflect the segregation of color forms in <i>Spiranthes sinensis</i> (Pers.) Ames complex (Orchidaceae) in the Chinese Himalayas?Zhi-Bin Tao, Zong-Xin Ren, Peter Bernhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 StudyChristopher Eigler, Lisa McDougall, Andreas Bauman, et al.
Cardiology Journal|October 25, 2017
Myocardial strain characteristics and outcomes after transcatheter aortic valve replacementDominik Buckert, Raid Tibi, Maciej Cieslik, et al.
Transplantation|March 24, 2023
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM StudyClaudia Sommerer, Christophe Legendre, Franco Citterio, et al.
Cancers|April 30, 2021
Dosimetric Analysis of the Short-Ranged Particle Emitter <sup>161</sup>Tb for Radionuclide Therapy of Metastatic Prostate CancerPeter Bernhardt, Johanna Svensson, Jens Hemmingsson, et al.
EJNMMI Physics|May 9, 2026
Multiple vertebrae improves precision in image-based bone marrow absorbed dose estimation in [<sup>177</sup>Lu]Lu-DOTATATE treatmentKatja Smits, Frida Westerbergh, Jens Hemmingsson, et al.
Pageof 23